Showing results (1291-1300 of 1,408) with videos related to

Sort By:
Pageof 141
Blood|November 19, 2008
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allograftingMarcello Rotta, Barry E Storer, Firoozeh Sahebi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantationR A Nash, M Yunosov, K Abrams, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Centromeric transposable elements and epigenetic status drive karyotypic variation in the eastern hoolock gibbonGabrielle A Hartley, Mariam Okhovat, Savannah J Hoyt, et al.
The New Zealand Medical Journal|June 21, 2022
Clinical features of patients hospitalised with COVID-19 from February to October 2020, during the early waves of the pandemic in New ZealandAliya Bryce, Lydia Foley, Juliette Phillipson, et al.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
Mutation Research|July 27, 2010
Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studiesAndreas Rothfuss, Mike O'Donovan, Marlies De Boeck, et al.
Contemporary Clinical Trials|May 10, 2017
Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitationShalender Bhasin, Caroline M Apovian, Thomas G Travison, et al.
ACS Chemical Biology|September 13, 2022
Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β BromodomainsAngelina R Sekirnik, Jessica K Reynolds, Larissa See, et al.
The Lancet. Haematology|June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trialBrenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemiaMohamed L Sorror, Michael B Maris, Brenda M Sandmaier, et al.
Pageof 141